We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTVE
3176
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
-306,803
Closed -$3.49M
EDR
3177
DELISTED
Endeavor Group Holdings, Inc.
EDR
-290,705
Closed -$6.55M
NKGN
3178
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
-589,724
Closed -$5.87M
BYNO
3179
DELISTED
byNordic Acquisition Corporation Class A Common Stock
BYNO
-742,498
Closed -$7.57M
RFAC
3180
DELISTED
RF Acquisition Corp. Class A Common Stock
RFAC
-184,665
Closed -$1.87M
EVGR
3181
DELISTED
Evergreen Corporation Class A Ordinary Share
EVGR
-63,102
Closed -$649K
CRKN
3182
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
-$7.77K
TETE
3183
DELISTED
Technology & Telecommunication Acquisition Corporation Class A Ordinary Shares
TETE
-45,200
Closed -$465K
PPYA
3184
DELISTED
Papaya Growth Opportunity Corp. I Class A Common Stock
PPYA
-783,450
Closed -$8.01M
BRAC
3185
DELISTED
Broad Capital Acquisition Corp Common Stock
BRAC
-154,856
Closed -$1.58M
GATO
3186
DELISTED
Gatos Silver, Inc.
GATO
-31,931
Closed -$131K
IVCB
3187
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
-200,398
Closed -$2.06M
NAPA
3188
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
-245,426
Closed -$4.07M
BFAC
3189
DELISTED
Battery Future Acquisition Corp.
BFAC
-806,845
Closed -$8.29M
BOCN
3190
DELISTED
Blue Ocean Acquisition Corp Class A Ordinary Shares
BOCN
-187,310
Closed -$1.93M
APXI
3191
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
-119,600
Closed -$1.23M
GLLI
3192
DELISTED
Globalink Investment Inc. Common Stock
GLLI
-483,804
Closed -$4.93M
IGTA
3193
DELISTED
Inception Growth Acquisition Limited Common Stock
IGTA
-88,097
Closed -$896K
IVCP
3194
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
-255,751
Closed -$2.59M
TCS
3195
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
-6,217
Closed -$402K
TLGY
3196
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
-352,479
Closed -$3.61M
TGAA
3197
DELISTED
Target Global Acquisition I Corp. Class A Ordinary Share
TGAA
-540,792
Closed -$5.54M
WEL
3198
DELISTED
Integrated Wellness Acquisition Corp
WEL
-292,016
Closed -$3M
RCM
3199
DELISTED
R1 RCM Inc. Common Stock
RCM
-25,400
Closed -$278K
CBRG
3200
DELISTED
Chain Bridge I Class A Ordinary Shares
CBRG
-401,099
Closed -$4.12M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.